Paolo Mercantini

Dr. Paolo Mercantini


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2011 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MTMarco La Torre
Marco La Torre
MCMarco Cavallini
Marco Cavallini
GRGiovanni Ramacciato
Giovanni Ramacciato
GCGiulia Cosenza
Giulia Cosenza
SMSimone Rossi del Monte
Simone Rossi del Monte
VZVincenzo Ziparo
Vincenzo Ziparo

Verified
Journal Article
Open access
PDF file
LMLUDOVICA MAGI
LUDOVICA MAGI
FMFederica Mazzuca
Federica Mazzuca
MRMaria Rinzivillo
Maria Rinzivillo
GAGiulia Arrivi
Giulia Arrivi
EPemanuela pilozzi
emanuela pilozzi
Francesco PanzutoFrancesco Panzuto
Francesco Panzuto
Purpose: Multidisciplinary approach is widely advised for an effective care of patients with neuroendocrine neoplasia (NEN). Since data on efficacy of multidisciplinary management of NENs patients in referral centers are scanty, this study aimed at analyzing the modality of presentation and clinical outcome of patients with NENs managed by a dedicated multidisciplinary team. Methods. In this prospective observational study, we included all consecutive new patients visiting the Sant’Andrea Hospital in Rome (ENETS—Center of Excellence) between January 2014 and June 2018. Results. A total of 195 patients were evaluated. The most frequent sites were pancreas (38.5%), small bowel (22%), and lung (9.7%). Median Ki67 was 3%. After the first visit at the center, additional radiological and/or nuclear medicine procedures were requested in 163 patients (83.6%), whereas histological data revision was advised in 84 patients (43.1%) (revision of histological slides: 27.7%, new bioptic sampling: 15.4%). After that, disease imaging staging and grading was modified in 30.7% and 17.9% of patients, respectively. Overall, a change in therapeutic management was proposed in 98 patients (50.3%). Conclusions. Multidisciplinary approach in a dedicated team may lead to change of disease imaging staging and grading in a significant proportion of patients. Enhancing referral routes to dedicated-NEN center should be promoted, since it may improve patients’ clinical outcome.

30 January 2013 in Muscle & Nerve
Verified
Journal Article
Open access
PDF file
ABAndrea Bonetto
Andrea Bonetto
FPFabio Penna
Fabio Penna
ZAZaira Aversa
Zaira Aversa
Paolo MercantiniPaolo Mercantini
Paolo Mercantini
FBFrancesco M. Baccino
Francesco M. Baccino
MMMaurizio Muscaritoli
Maurizio Muscaritoli
Introduction Cachexia increases morbidity and mortality of cancer patients. The progressive loss of muscle mass negatively affects physical function and quality of life. We previously showed reduced muscle insulin-like growth factor-1 (IGF-1) expression and enhanced myostatin signaling in tumor-bearing animals. This study was aimed at investigating whether similar perturbations occur in gastric cancer patients. Methods Early perturbations of myostatin and IGF-1 signaling (including the expression of muscle-specific ubiquitin ligases) were investigated in 16 gastric cancer patients and in 6 controls by analyzing muscle mRNA expression with semiquantitative reverse transcriptase polymerase chain reaction (PCR) and real-time PCR. Results In gastric cancer patients, muscle mRNA levels for IGF-1, myostatin, and atrogin-1 were reduced irrespective of weight loss (≤5% or >5%), whereas MuRF1 expression was unchanged. Conclusions IGF-1 and myostatin mRNA levels are downregulated in gastric cancer patients who have minimal or no weight loss. These early alterations are particularly relevant in order to devise preventive and therapeutic strategies for cancer cachexia. Muscle Nerve 48: 387–392, 2013

1 March 2011
Verified
Journal Article
Closed access
GRGiovanni Ramacciato
Giovanni Ramacciato
Paolo MercantiniPaolo Mercantini
Paolo Mercantini
Niccolò PetruccianiNiccolò Petrucciani
Niccolò Petrucciani
Giuseppe NigriGiuseppe Nigri
Giuseppe Nigri
AKAndrea Kazemi
Andrea Kazemi
Matteo RavaioliMatteo Ravaioli
Matteo Ravaioli

5 November 2020 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
GGgiovanni maria garbarino
giovanni maria garbarino
Gianluca CostaGianluca Costa
Gianluca Costa
BFBarbara Frezza
Barbara Frezza
ABAlessia Biancafarina
Alessia Biancafarina
GBGenoveffa BAlducci
Genoveffa BAlducci
GCGraziano Ceccarelli
Graziano Ceccarelli
Although there is no agreement on a definition of elderly, commonly an age cutoff of ≥ 65 or 75 years is used. Even if robot-assisted surgery is a validated option for the elderly population, there are no specific indications for its application in the surgical treatment of gastric cancer. The aim of this study is to evaluate the safety and feasibility of robot-assisted gastrectomy and to compare the short and long-term outcomes of robot-assisted (RG) versus open gastrectomy (OG). Patients aged ≥ 70 years old undergoing surgery for gastric cancer at the Department of Surgery of San Donato Hospital in Arezzo, between September 2012 and March 2017 were enrolled. A 1:1 propensity score matching was performed according to the following variables: age, Sex, BMI, ASA score, comorbidity, T stage and type of resection performed. 43 OG were matched to 43 RG. The mean operative time was significantly longer in the RG group (273.8 vs. 193.5 min, p < 0.01). No differences were observed in terms of intraoperative blood loss, an average number of lymph nodes removed, mean hospital stay, morbidity and mortality. OG had higher rate of major complications (6.9 vs. 16.3%, OR 2.592, 95% CI 0.623–10.785, p = 0.313) and a significantly higher postoperative pain (0.95 vs. 1.24, p = 0.042). Overall survival (p = 0.263) and disease-free survival (p = 0.474) were comparable between groups. Robotic-assisted surgery for oncological gastrectomy in elderly patients is safe and effective showing non-inferiority comparing to the open technique in terms of perioperative outcomes and overall 5-year survival.

Verified
Journal Article
Open access
PDF file
GGgiovanni maria garbarino
giovanni maria garbarino
GLGiovanni Guglielmo Laracca
Giovanni Guglielmo Laracca
ALAlessio Lucarini
Alessio Lucarini
GPGianmarco Piccolino
Gianmarco Piccolino
Paolo MercantiniPaolo Mercantini
Paolo Mercantini
Gianluca CostaGianluca Costa
Gianluca Costa
Background. The advantages of a laparoscopic approach for the treatment of gastric cancer have already been demonstrated in Eastern Countries. This review and meta-analysis aims to merge all the western studies comparing laparoscopic (LG) versus open gastrectomies (OG) to provide pooled results and higher levels of evidence. Methods. A systematic literature search was performed in MEDLINE(PubMed), Embase, WebOfScience and Scopus for studies comparing laparoscopic versus open gastrectomy in western centers from 1980 to 2021. Results. After screening 355 articles, 34 articles with a total of 24,098 patients undergoing LG (5445) or OG (18,653) in western centers were included. Compared to open gastrectomy, laparoscopic gastrectomy has a significantly longer operation time (WMD = 47.46 min; 95% CI = 31.83–63.09; p < 0.001), lower blood loss (WMD = −129.32 mL; 95% CI = −188.11 to −70.53; p < 0.0001), lower analgesic requirement (WMD = −1.824 days; 95% CI = −2.314 to −1.334; p < 0.0001), faster time to first oral intake (WMD = −1.501 days; 95% CI = −2.571 to −0.431; p = 0.0060), shorter hospital stay (WMD = −2.335; 95% CI = −3.061 to −1.609; p < 0.0001), lower mortality (logOR = −0.261; 95% the −0.446 to −0.076; p = 0.0056) and a better 3-year overall survival (logHR 0.245; 95% CI = 0.016–0.474; p = 0.0360). A slight significant difference in favor of laparoscopic gastrectomy was noted for the incidence of postoperative complications (logOR = −0.202; 95% CI = −0.403 to −0.000 the = 0.0499). No statistical difference was noted based on the number of harvested lymph nodes, the rate of major postoperative complication and 5-year overall survival. Conclusions. In Western centers, laparoscopic gastrectomy has better short-term and equivalent long-term outcomes compared with the open approach, but more high-quality studies on long-term outcomes are required.